Assuring sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programmes – for lung, prostate and gastric cancers.
Europeans are disproportionately affected by cancer: while we make up only one tenth of the world population, about one in four of all annual cancer cases occurs in Europe. In 2020, there were about four million new cancer cases, and 1.9 million people are estimated to have died from cancer in Europe. In the European Union countries 2.7 million people were diagnosed with cancer and 1.3 million died due to cancer in 2020. The earlier cancer is diagnosed and treated, the greater the chances of survival. Prevention and early detection through population-based screening approaches and early diagnosis are critically important interventions of comprehensive cancer control policies.
The Europe’s Beating Cancer Plan has called for a new EU-Supported Cancer Screening Scheme to assure high performance of cancer screening programmes across all Member States (MS). The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programmes – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
Seven specific objectives have been set for EUCanScreen:
1. ensuring full implementation of evidence-based, cost-effective and quality-assured screening programmes for breast, cervical and colorectal cancers;
2. preparing for implementation of evidence-based, cost-effective and quality-assured screening programmes for lung, prostate and gastric cancers;
3. ensuring proper programme governance and sustainability;
4. ensuring better-quality, timelier and comparable data collection and monitoring of screening programmes;
5. ensuring equal access of eligible EU citizens to screening programmes and reducing cancer inequalities;
6. ensuring capacity building in cancer screening, and
7. ensuring collaboration and coherence with related projects funded under EU Programmes.
The work-plan of EUCanScreen has been built on the results of previous and ongoing major EU screening activities and is composed of eleven interlinked work packages.
EUCanScreen is an EU project in which 29 partnering countries are represented, including 25 EU MS, 2 EU candidate countries (Ukraine and Moldova) and 2 countries in the European Free Trade Association (Norway and Iceland). Malta is represented in the Consortium by the Ministry for Health and Active Ageing.
Project ID No.: 101162959
Project implementation: 01.06.2024. – 31.05.2028.
Total project funding: 38 749 935 EUR
Project Coordinator: University of Latvia (Latvijas Universitāte)
Email: [email protected]
• UNIVERSITY OF LATVIA (LU)
• GESUNDHEIT OSTERREICH GMBH (AT)
• SCIENSANO (BE)
• HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (HR)
• Ministry of Health of the Republic of Cyprus (CY)
• USTAV ZDRAVOTNICKYCH INFORMACI A STATISTIKY CESKE REPUBLIKY (CZ)
• REGION SYDDANMARK (DK)
• TERVISE ARENGU INSTITUUT (EE)
• TERVEYDEN JA HYVINVOINNIN LAITOS (FI)
• INSTITUT NATIONAL DU CANCER GIP (FR)
• ROBERT KOCH-INSTITUT (DE)
• MINISTRY OF HEALTH (EL)
• ORSZAGOS KORANYI PULMONOLOGIAI INTEZET (HU)
• HEILSUGAESLA HOFUDBORGARSVAEDISINS (IS)
• DEPARTMENT OF HEALTH (IE)
• ISTITUTO PER LO STUDIO E LA PREVENZIONE E LA RETE ONCOLOGICA (IT)
• LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJA (LT)
• Ministry for Health and Active Ageing – Government of Malta (MT)
• INSTITUTIA MEDICO-SANITARA PUBLICA INSTITUTUL ONCOLOGIC (MD)
• RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL)
• HELSEDIREKTORATET (NO)
• NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE – PANSTWOWY INSTYTUT BADAWCZY (PL)
• MINISTERIO DA SAUDE – REPUBLICA PORTUGUESA (PT)
• INSTITUTUL NATIONAL DE SANATATE PUBLICA (RO)
• MINISTERSTVO ZDRAVOTNICTVA SLOVENSKEJ REPUBLIKY (SK)
• ONKOLOSKI INSTITUT LJUBLJANA (SI)
• INSTITUT CATALA D’ONCOLOGIA (ES)
• SOCIALSTYRELSEN (SE)
• STATE INSTITUTION PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE (UA)
• SLIMĪBU PROFILAKSES UN KONTROLES CENTRS (LV)
• RĪGAS STRADIŅA UNIVERSITĀTE (LV)
• PAULA STRADIŅA KLĪNISKĀ UNIVERSITĀTES SLIMNĪCA (LV)
• UNIVERSITAT FUR WEITERBILDUNG KREMS (AT)
• UMIT TIROL – PRIVATE UNIVERSITAT FUR GESUNDHEITSWISSENSCHAFTEN UND TECHNOLOGIE GMBH (AT)
• CENTRUM VOOR KANKEROPSPORING (BE)
• STICHTING KANKERREGISTER – FONDATION REGISTRE DU CANCER (BE)
• CENTRE COMMUNAUTAIRE DE REFERENCE POUR LE DEPISTAGE DES CANCERS (BE)
• UNIVERSITAIR ZIEKENHUIS ANTWERPEN (BE)
• CENTRE BRUXELLOIS DE COORDINATION POUR LE DEPISTAGE ET LA PREVENTION DES CANCERS (BE)
• KLINICKI BOLNICKI CENTAR ZAGREB (HR)
• UNIVERSITY OF CYPRUS (CY)
• TARTU ULIKOOL (EE)
• SUOMEN SYOPAYHDISTYS – CANCERFORENINGEN I FINLAND RY – CANCER SOCIETY OF FINLAND CSF (FI)
• FEDERATION HOSPITALIERE DE FRANCE (FR)
• HOSPICES CIVILS DE LYON (FR)
• UNICANCER (FR)
• ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (FR)
• PLATEFORME DES DONNEES DE SANTE (FR)
• DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DE)
• LEIBNIZ-INSTITUT FUR PRAVENTIONSFORSCHUNG UND EPIDEMIOLOGIE – BIPS GMBH (DE)
• DEUTSCHE KREBSGESELLSCHAFT EV (DE)
• DIOIKISI 6IS YGEIONOMIKIS PERIFEREIAS PELOPONNISOU IONION NYSON IPEIROU KAI DYTIKIS ELLADAS (EL)
• NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT (HU)
• LANDLAEKNIS EMBAETTID (IS)
• HEALTH SERVICE EXECUTIVE (IE)
• ROYAL COLLEGE OF SURGEONS IN IRELAND (IE)
• ISTITUTO SUPERIORE DI SANITA (IT)
• MINISTERO DELLA SALUTE (IT)
• AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA (IT)
• REGIONE MARCHE (IT)
• AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO (IT)
• AZIENDA ULSS 4 VENETO ORIENTALE (IT)
• ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (IT)
• UNIVERSITA CATTOLICA DEL SACRO CUORE (IT)
• PROVINCIA AUTONOMA DI TRENTO (IT)
• FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (IT)
• REGIONE LOMBARDIA (IT)
• ATS PAVIA (IT)
• VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS (LT)
• LIETUVOS SVEITAKOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS (LT)
• ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (NL)
• STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (NL)
• STICHTING BEVOLKINGSONDERZOEK NEDERLAND (NL)
• FOLKEHELSEINSTITUTTET (NO)
• INSTYTUT GRUZLICY I CHOROB PLUC (PL)
• INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL, EPE (PT)
• UNIDADE LOCAL DE SAUDE DE SAO JOAO, E.P.E. (PT)
• UNIDADE LOCAL DE SAÚDE SANTA MARIA (PT)
• INSTITUTUL CLINIC FUNDENI (RO)
• INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA CLUJ-NAPOCA (RO)
• NARODNY ONKOLOGICKY USTAV (SK)
• NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (SI)
• ASOCIACIÓN INSTITUTO DE INVESTIGACIÓN EN SISTEMAS DE SALUD-BIOSISTEMAK (ES)
• FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (ES)
• INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (ES)
• FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA (ES)
• FUNDACIO INSTITUT HOSPITAL DEL MAR D INVESTIGACIONS MEDIQUES (ES)
• SVERIGES KOMMUNER OCH REGIONER (SE)
• STATE INSTITUTION VOZIANOV INSTITUTE OF UROLOGY OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE (UA)
• NATIONAL CANCER INSTITUTE (UA)
• INSTITUT JULES BORDET ASBL (BE)
• MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT (NL)
• INSTITUTO TUMORI “GIOVANNI PAOLO II” IRCCS (IT)
• AZIENDA SANITARIA LOCALE TARANTO (IT)
• MSB MEDICAL SCHOOL BERLIN GMBH (DE)
• CENTRUL NATIONAL DE SANATATE MINTALA SI LUPTA ANTODROG (RO)
• INSTITUTUL REGIONAL DE ONCOLOGIE IASI (RO)
Dr. Sascha Reiff
Consultant in Public Health Medicine
[email protected]
This project has received funding from the European Union’s EU4HEALTH Programme under Grant Agreement no 101162959.
Funding period: 01/06/2024 – 31/05/2028
